Novavax gathers its COVID-19 vaccine data for long-delayed FDA filingnews2022-01-04T14:15:52+00:00January 4th, 2022|Fierce Pharma|
Continuus Pharma to build $125M manufacturing site in Massachusettsnews2022-01-04T14:06:36+00:00January 4th, 2022|Fierce Pharma|
Novo Holdings buys sterile injectables maker Ritedose for undisclosed pricenews2022-01-04T13:31:08+00:00January 4th, 2022|Fierce Pharma|
Arcutis reups ahead of critical year for topical drug delivery tech, securing $225M debt financing to fund product launch, pivotal readoutsnews2022-01-04T11:39:54+00:00January 4th, 2022|Fierce Pharma|
GSK targets the future of multiple myeloma with new think tank challengenews2022-01-04T08:39:13+00:00January 4th, 2022|Fierce Pharma|
EyeD lands $51M to take glaucoma implant into the clinicnews2022-01-03T14:51:40+00:00January 3rd, 2022|Fierce Pharma|
SanPlena sets out to show wearable patches are the key to faster weight lossnews2022-01-03T14:48:32+00:00January 3rd, 2022|Fierce Pharma|
Oravax inks oral COVID-19 vaccine supply deal amid talks about public listingnews2022-01-03T14:44:51+00:00January 3rd, 2022|Fierce Pharma|
MassBio report highlights racial disparities in biopharma workforce, improvement in gender diversity on boardsnews2022-01-01T01:53:03+00:00January 1st, 2022|Fierce Pharma|
Racial disparities continue to plague biopharma workforce, report finds—but boards do have more womennews2022-01-01T01:53:03+00:00January 1st, 2022|Fierce Pharma|
